Chemistry Reference
In-Depth Information
CO
2
H
O
H
O
N
Repaglinide
Thiazolidinediones are a class of insulin-sensitizing drugs. Their use is lim-
ited because they can cause congestive heart failure. Troglitazone (Rezulin
®
)
was approved in the U.S. in 1997 followed in 1999 by pioglitazone and rosigli-
tazone [47]. Troglitazone was withdrawn from the market in 2000 due to liver
toxicity. Pioglitazone is available as the hydrochloride salt (Actos
®
, Takeda)
and rosiglitazone as the maleate salt (Avandia
®
, GlaxoSmithKline). There
are also concerns with pioglitazone and rosiglitazone (risk of cardiac events)
and this precludes their use in some patients.
Thiazolidinedione ring
O
NH
S
O
O
O
HO
Troglitanzone
O
CO
2
H
CH
3
NH
S
N
N
CO
2
H
O
O
Rosiglitazone maleate
O
N
NH
HCl
S
O
O
Pioglitazone hydrochloride
Notice that there is a chiral carbon in these structures. They are present as
a racemic mixture of enantiomers. The enantiomers interconvert rapidly in
vivo and there is no difference in the pharmacologic activity between the two
enantiomers.
Chiral carbon
O
NH
S
R
O
O
Incretin
hormones
such
as
glucagon-like
peptide
1
(GLP-1)
cause
-cells. Exenatide (Byetta
®
, Amylin
insulin release from the pancreatic
β
Search WWH ::
Custom Search